Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

http://www.wikidata.org/entity/Q34098866

about

Direct detection of alternative open reading frames translation products in human significantly expands the proteome Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening Current status of biomarker research in neurology Revolutionizing Alzheimer's disease and clinical trials through biomarkers Clinical proteomics of enervated neurons Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics Pro-Apoptotic Kinase Levels in Cerebrospinal Fluid as Potential Future Biomarkers in Alzheimer's Disease Clearance systems in the brain-implications for Alzheimer disease Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal Variation Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD Biological markers of Alzheimer's disease Role of HIV in amyloid metabolism Carnosinases, their substrates and diseases Body fluid biomarkers in Alzheimer's disease Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria Platelets and Alzheimer's disease: Potential of APP as a biomarker The role of tau in neurodegenerative diseases and its potential as a therapeutic target A window into the heterogeneity of human cerebrospinal fluid Aβ peptides Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models HSV-1 and Alzheimer's disease: more than a hypothesis.Exploring Biomarkers for Alzheimer's Disease Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system Metabolite profiling of Alzheimer's disease cerebrospinal fluid High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease Exploiting thermodynamic data to optimize the enantioseparation of underivatized amino acids in ligand exchange capillary electrophoresis.

P2860

Q21132658-FEAAD262-BD8A-49A3-9E81-F9CF9961106F Q24289435-AF44C7B3-764E-4F8D-96DB-E466BF8DF981 Q24630334-9B5FD904-B609-433B-A622-FF9DB5431854 Q26744505-E7C5E6FB-E86C-4C83-8F71-9FC70379ADE4 Q26744882-6B20BAE2-1E38-4737-A607-DA4F8E019862 Q26752052-F92F31E9-D319-47FB-AC0F-8F382421CF69 Q26781562-3AC52B71-EEEA-4510-A63D-08BC27BD566F Q26784569-CCA48733-3FB8-4DBE-BC79-B6A89F52E2D4 Q26795492-8F357CF2-BE63-4B23-B1A3-757DAB08CCCB Q26801541-24568DE3-1E32-4ED3-BD20-E932A1F4851C Q26801663-84C7D364-12D5-488F-A7D4-E8E8F3678915 Q26801666-CA0B4D9B-B045-4D4D-A78F-1927D916387C Q26823847-A674A022-A0B1-49D0-B212-52E67920230D Q26824179-F7FE6BC6-7605-404C-8CFE-EBB96FB9E57A Q26829095-4FDD28EF-ACBB-46DC-A53B-43E68F80DCC1 Q26830098-78C42B5E-4625-47B4-AC7D-09830871531A Q26864063-382270DE-66F6-4843-84C9-3F3CE922B276 Q27001550-86E5A33E-3696-47DB-8818-930237045DBF Q27005032-CE50471A-1B7C-4071-9DCE-A5503F73AB1D Q27010785-EDE3C4E1-DFB0-4699-8B11-7220AE05C660 Q27024518-8D03F213-4A02-4F5C-83C2-F1E05BA476F4 Q27027319-E298F222-1DD6-42E4-9E1D-4AF27DE23D09 Q27308146-765CCA52-7A3D-48F6-BACB-FB66440BD813 Q27692651-EB4FCB2B-D5F4-4390-A4C6-91C631E7F950 Q28079218-B29D5104-76F3-46C8-B639-D14DCEBADB82 Q28087176-054DA017-C268-49BA-8DE8-FD0B02C5542A Q28480522-06FCE966-086D-471C-A0C4-8E5C1D849A97 Q28480903-FB767E6A-6453-4C2D-8109-368A2D09B831 Q28547231-21C40FF7-CEA4-4520-A5A3-229BED067E08 Q28582464-411DBE31-B32F-43DB-B930-4759E962E84F Q28595520-7E3AB6A6-BACF-4D7C-BD25-D80C456A7C07 Q28687678-50793081-DFFF-4E97-BF97-441151A11B2A Q28728080-EB9268FC-92FB-4583-A5ED-78E95834A93C Q28730795-5606DF45-A832-4024-ABD3-DC93649DADB5 Q28740764-BE03874D-7FA1-4D9C-96F6-B0CD329314E9 Q28743838-9D2854A6-7A3E-4C03-8694-F11974942159 Q29417147-C7109D25-B1B0-4E70-84E4-477E6E61D856 Q30235315-5C8CAF8C-B9E1-45A7-AC11-D63B2F4F4514 Q30497749-0FBE78C0-452A-4DD3-9DE8-0B6681807C80 Q30563736-B31252CD-394A-46C1-BDAF-57B29A2AA735

P2860

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

http://www.wikidata.org/entity/Q34098866

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@ast

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@en

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@nl

type

label

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@ast

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@en

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@nl

prefLabel

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@ast

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@en

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@nl

P1433

Q34098866-A8FA346E-1C17-47EC-A6CC-78100C3CFBD7

P1476

Q34098866-80377375-F9EB-4F6A-9CC6-393C45F82B25

P2093

Q34098866-074800F9-2D78-403D-8E84-9FD6921D4133

P2860

Q34098866-1AC175C0-C408-45D5-B1F4-C3E2EE6F228D

Q34098866-63104FA2-51CA-4417-B8EE-988F7EA5BAD5

Q34098866-8565CDC3-4AC6-4892-8D70-334D1CF4B381

Q34098866-BF592BC2-B7C5-465B-991C-F4A747BDD8BC

Q34098866-D8BD4056-E6A9-4174-ACD6-5A86E3C7AAE7

Q34098866-D9ABE900-676E-4AD0-8887-0B4F53F98493

Q34098866-F29FDD9A-4D4F-4C0B-BC98-3A4CE0F7D459

Q34098866-F308462D-B213-4C2B-BA4C-71A10827C062

P2888

Q34098866-53E2CE87-384F-4E73-B3C2-BB3799DC4274

P304

Q34098866-5B9A1A81-5A87-45D2-99C0-C7CC7AA85188

P31

Q34098866-DDE6E115-51D5-42F7-BDF2-B3D5FD73770E

P356

Q34098866-E051AA0B-6212-440E-9624-7BBD2C37F329

P407

Q34098866-3D11ABDF-76C2-4FF5-BF2D-6F4946A64805

P433

Q34098866-574EE472-3EE8-437E-B16F-D21B767A80E0

P478

Q34098866-DDC25868-38E2-436A-AC2A-BD8456906221

P50

Q34098866-64DA0F8F-A5D0-4B7A-85DC-4B69136EE26F

Q34098866-AE0B5CFA-0AAD-471F-B3FB-28F8481B90DC

Q34098866-CEEFC11E-29D7-4C61-AF27-32B53438B89A

P577

Q34098866-AF5A46DB-7EC3-42AF-BFF9-10709B57DE88

P5875

Q34098866-67FFDF29-93CB-463A-8E96-1D3F7E66EC4F

P6179

Q34098866-2739CC32-AFA1-4086-91CA-C17C8F81C135

P698

Q34098866-787A908C-3233-4944-A76C-DEBA30B892F5

P921

Q34098866-4CB844D7-5E0C-4E7F-82BB-6BA0C9CE3452

Q34098866-5D4EF28F-062F-4879-A29C-9D598327F357

Q34098866-7407D32E-2FBF-4FA8-9CA8-90F50EA6A103

P356

NRNEUROL.2010.4

P1433

Nature Reviews Neurology

P1476

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

@en

P2093

Michael Weiner

http://www.w3.org/2001/XMLSchema#string

P2860

Tau pathology in Alzheimer disease and other tauopathies

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Distribution of tau proteins in the normal human central and peripheral nervous system.

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

Aging and Alzheimer's disease: lessons from the Nun Study.

P2888

nrneurol.2010.4

P304

131-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2010.4

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2010-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41435687

http://www.w3.org/2001/XMLSchema#string

P6179

1016181353

http://www.w3.org/2001/XMLSchema#string

P698

20157306

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid